Predicting risk of type-2 diabetes in high risk Australian men
A tool for researchers and health care professionals to prognosticate the risk at diabetes in high risk Australian men who may be treated with testosterone. This score was developed from the T4DM trial.
This is appropriate for men at higher risk risk of developing diabetes, aged 50 to 74 years, waist circumference >=95 cm, with impaired glucose tolerance or newly diagnosed type 2 diabetes, and a fasting serum testosterone of >=14 nmol/L. The risk score is predicting the risk of diabetes at two years, with higher scores indicating higher risk.
If this patient was receive NO TESTOSTERONE TREATMENT, the risk of diabetes at two years is:
If this patient was receive TESTOSTERONE TREATMENT, the risk of diabetes at two years is:
Disclaimer & Privacy
The NHMRC Clinical Trials Centre (CTC) strives to keep information stored in this T2D risk prediction tool is up to date, but does not guarantee the accuracy, reliability or currency of the information. Any errors in the information that are brought to our attention will be corrected as soon as possible. The CTC reserves the right to change at any time without notice any information stored in this T2D risk prediction tool.